Location History:
- Hoofddorp, NL (2014 - 2017)
- Hooffddorp, NL (2020)
Company Filing History:
4 out of 13 
3 out of 822 
1 out of 1 Years Active: 2014-2020
Title: Pieter Smid: Innovator in Pharmaceutical Chemistry
Introduction
Pieter Smid is a prominent inventor based in Hoofddorp, Netherlands. He holds a total of four patents, showcasing his significant contributions to the field of pharmaceutical chemistry, particularly in the development of S1P modulators.
Latest Patents
Among his latest inventions are two notable patents that focus on fused heterocyclic derivatives as S1P modulators. The first invention relates to new compounds that exhibit affinity to S1P receptors. These compounds are described as useful for preparing medicaments aimed at treating, alleviating, or preventing diseases that involve S1P receptors, or modulation of the endogenous S1P signaling system. The second patent similarly details a fused heterocyclic derivative, recognized as a modulator of the S1P receptor, specifically as an agonist of S1P5. The therapeutic applications of these compounds include the treatment of cognitive disorders, age-related cognitive decline, and dementia.
Career Highlights
Throughout his career, Pieter Smid has worked with esteemed companies such as AbbVie B.V. and AbbVie Inc. His work has had a profound impact on the development of innovative pharmaceutical solutions, particularly in targeting S1P receptors.
Collaborations
Pieter Smid has collaborated with notable colleagues, including Wouter I. Iwema Bakker and Hein K. A. C. Coolen. Together, they have contributed to advancements in pharmaceutical research and development.
Conclusion
Pieter Smid's inventive spirit and commitment to advancing pharmaceutical science through his patents underscore his status as a leading figure in the industry. His work in developing S1P modulators has the potential to bring significant benefits to patients suffering from cognitive disorders and related conditions.